SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
CD4-Targeted IL-15 Enhanced bNAb Activity and Improved SHIV Control After Treatment Interruption
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
CD4-Targeted IL-15 Enhanced bNAb Activity and Improved SHIV Control After Treatment Interruption (ABSTRACT
137)
Jeffrey Murry
Gilead Sciences, Inc, Foster City, CA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
